Recurrent Clear Cell Renal Cell Carcinoma
1 clinical trials · Condition
◉ Watch Recurrent Clear Cell Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab With or Without Axitinib for Clear Cell Kidney Cancer in Patients Undergoing Surgery (NCT04370509) | University of California, San Francisco | 2021-02-09 |
Track Recurrent Clear Cell Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.